< %=imgalt%>
Home / Technology News / 2008 / June 2008 / June 17, 2008
Australia develops human vaccine for bird flu
Bird Flu

12 deadly diseases worsened by climate change enlisted

MedImmune Licenses Reverse Genetics Technology to Japan's BIKEN for Use in Influenza Vaccine Development and Production

The Grid will revolutionize download speed in personal computers

Research Shows How AHCC(R) May Help Fight Flu and Other Infectious Agents

More on Bird Flu

Top News

Praja Rajyam Party tour programme announced

J-K police recruit 110 special police officers

Now, a range of beds that can also be banks!

Dead junkie pals pic made Cheryl Cole stay off drugs for life

RBI Governor says fundamentals of Indian economy continue to be strong

Tiger Woods vows to keep babys sex secret

Website lets netizens create a perfect candidate U.S. presidential candidate

New 2008 Edition of Times Higher-QS World University Rankings Released on October 8,2008

Australia develops human vaccine for bird flu

A vaccine to protect people against bird flu has been developed in Australia, said the countrys federal Health Minister.

Melbourne, June 17 : A vaccine to protect people against bird flu has been developed in Australia, said the country's federal Health Minister.

"The first ever Australian-made vaccine to protect humans from future bird flu pandemics has been granted approval for use in the event, of course, of an avian influenza outbreak," News.com.au quoted Nicola Roxon, as saying.

The vaccine, developed by CSL, would protect humans against the H5N1 strain of influenza responsible for outbreaks of bird flu in Asia, the Middle East, Europe and Africa, Roxon said.

"We know, of course, that if there is an outbreak that affects Australians, we need to make sure that we are properly prepared," she said.

She added: "What we now have, courtesy of the work done by CSL ... is an Australian-made and able to be manufactured in Australia vaccine which will be able to respond to any new strain of a virus.

"We are very pleased that now that approvals have been granted that if we are in a situation which, of course, we hope we won't be, of a human-to-human virus taking hold in Australia, we will be able to quickly respond."

In that event, there would be no need to go through the approvals process, Roxon said.

She said the safety of the vaccine had been assessed for adults aged 18-64 and those aged over 65.

The vaccine would be used only once an influenza pandemic had been officially declared by the World Health Organisation (WHO), Roxon said.

"We hope we are not in a situation that this occurs but it does pay for us to be ready," she said.

ANI

October 13, 2008

October 12, 2008

October 11, 2008

October 10, 2008

October 9, 2008

October 8, 2008